UCB
The Global Regulatory Affairs (GRA) Device Lead will support regulatory strategy and submissions for marketed and development medical devices and combination products, focusing on neurology, immunology, and new medicines, including cell and gene therapies. The role involves preparing technical documentation, interacting with health authorities and notified bodies, and providing regulatory input to cross‑functional initiatives.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
Global Regulatory Affairs Device Lead, (Atlanta, GA)
City of Pierre, South Dakota
Regulatory Affairs Consultant: Medical Device and Combination Product Expert
Parexel
Fellow Regulatory Affairs
bostonscientific
GRA CMC Lead
sanofi us
Senior Regulatory Affairs Specialist
W&B Scientific, Inc.
Senior Director and Regulatory Platform Lead GRA CMC, Device and Drug-Device Combinations Human Factors
Takeda Pharmaceutical Company Limited